Literature DB >> 24990429

Treatment with LPS plus INF-γ induces the expression and function of muscarinic acetylcholine receptors, modulating NIH3T3 cell proliferation: participation of NOS and COX.

A J Español1, M O Maddaleno, M G Lombardi, M Cella, P Martínez Pulido, M E Sales.   

Abstract

BACKGROUND AND
PURPOSE: LPS and IFN-γ are potent stimuli of inflammation, a process in which fibroblasts are frequently involved. We analysed the effect of treatment with LPS plus IFN-γ on the expression and function of muscarinic acetylcholine receptors in NIH3T3 fibroblasts with regards to proliferation of these cells. We also investigated the participation of NOS and COX, and the role of NF-κB in this process. EXPERIMENTAL APPROACH: NIH3T3 cells were treated with LPS (10 ng·mL(-1)) plus IFN-γ (0.5 ng·mL(-1)) for 72 h (iNIH3T3 cells). Cell proliferation was evaluated with MTT and protein expression by Western blot analysis. NOS and COX activities were measured by the Griess method and radioimmunoassay respectively. KEY
RESULTS: The cholinoceptor agonist carbachol was more effective at stimulating proliferation in iNIH3T3 than in NIH3T3 cells, probably due to the de novo induction of M3 and M5 muscarinic receptors independently of NF-κB activation. iNIH3T3 cells produced higher amounts of NO and PGE2 than NIH3T3 cells, concomitantly with an up-regulation of NOS1 and COX-2, and with the de novo induction of NOS2/3 in inflamed cells. We also found a positive feedback between NOS and COX that could potentiate inflammation. CONCLUSIONS AND IMPLICATIONS: Inflammation induced the expression of muscarinic receptors and, therefore,stimulated carbachol-induced proliferation of fibroblasts. Inflammation also up-regulated the expression of NOS and COX-2, thus potentiating the effect of carbachol on NO and PGE2 production. A positive crosstalk between NOS and COX triggered by carbachol in inflamed cells points to muscarinic receptors as potential therapeutic targets in inflammation.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990429      PMCID: PMC4253462          DOI: 10.1111/bph.12834

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  Nitrosation and oxidation in the regulation of gene expression.

Authors:  H E Marshall; K Merchant; J S Stamler
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

2.  Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases.

Authors:  H Matsuura; M Sakaue; K Subbaramaiah; H Kamitani; T E Eling; A J Dannenberg; T Tanabe; H Inoue; J Arata; A M Jetten
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

Review 3.  Muscarinic acetylcholine receptors: signal transduction through multiple effectors.

Authors:  C C Felder
Journal:  FASEB J       Date:  1995-05       Impact factor: 5.191

4.  In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain.

Authors:  T R Chen
Journal:  Exp Cell Res       Date:  1977-02       Impact factor: 3.905

5.  Heterotrimeric Gα(i) proteins are regulated by lipopolysaccharide and are anti-inflammatory in endotoxemia and polymicrobial sepsis.

Authors:  Hongkuan Fan; Pengfei Li; Basilia Zingarelli; Keith Borg; Perry V Halushka; Lutz Birnbaumer; James A Cook
Journal:  Biochim Biophys Acta       Date:  2011-01-19

6.  Parainfluenza virus type 1 reduces the affinity of agonists for muscarinic receptors in guinea-pig lung and heart.

Authors:  A D Fryer; E E el-Fakahany; D B Jacoby
Journal:  Eur J Pharmacol       Date:  1990-05-31       Impact factor: 4.432

7.  Identification and molecular characterization of a m5 muscarinic receptor in A2058 human melanoma cells. Coupling to inhibition of adenylyl cyclase and stimulation of phospholipase A2.

Authors:  E C Kohn; R Alessandro; J Probst; W Jacobs; E Brilley; C C Felder
Journal:  J Biol Chem       Date:  1996-07-19       Impact factor: 5.157

8.  Different muscarinc receptors are involved in the proliferation of murine mammary adenocarcinoma cell lines.

Authors:  Alejandro J Español; María E Sales
Journal:  Int J Mol Med       Date:  2004-02       Impact factor: 4.101

9.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  6 in total

1.  Uterine Inflammation Changes the Expression of Cholinergic Neurotransmitters and Decreases the Population of AChE-Positive, Uterus-Innervating Neurons in the Paracervical Ganglion of Sexually Mature Gilts.

Authors:  Bartosz Miciński; Barbara Jana; Jarosław Całka
Journal:  Animals (Basel)       Date:  2022-06-29       Impact factor: 3.231

Review 2.  Neuroimmune Pathophysiology in Asthma.

Authors:  Gandhi F Pavón-Romero; Nancy Haydée Serrano-Pérez; Lizbeth García-Sánchez; Fernando Ramírez-Jiménez; Luis M Terán
Journal:  Front Cell Dev Biol       Date:  2021-05-13

3.  Escherichia Coli -induced Inflammation Changes the Expression of Acetylcholine Receptors (M2R, M3R, and α-7 nAChR) in the Pig Uterus.

Authors:  Barbara Jana; Jarosław Całka; Katarzyna Palus; Małgorzata Sikora
Journal:  J Vet Res       Date:  2020-11-06       Impact factor: 1.744

Review 4.  Multiple roles for cholinergic signaling in pancreatic diseases.

Authors:  Jun-Min Yang; Xiao-Yu Yang; Jian-Hua Wan
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

5.  An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease.

Authors:  Liqun Wang; Tracy L Hagemann; Albee Messing; Mel B Feany
Journal:  J Neurosci       Date:  2016-02-03       Impact factor: 6.167

Review 6.  Breast cancer: Muscarinic receptors as new targets for tumor therapy.

Authors:  Alejandro Español; Agustina Salem; Yamila Sanchez; María Elena Sales
Journal:  World J Clin Oncol       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.